Sienna Biopharmaceuticals Statistics
Sienna Biopharmaceuticals (SNNAQ) Stock Statistics & Valuation Metrics
Total Valuation
Sienna Biopharmaceuticals has a market cap or net worth of $31.00. The enterprise value is -$18.40T.
- Market Cap
- $31.00
- Enterprise Value
- -$18.40T
Share Statistics
Sienna Biopharmaceuticals has 30,908,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 30,908,000
- Owned by Insiders
- ―
- Owned by Institutions
- 7.44%
Financial Efficiency
Sienna Biopharmaceuticals’s return on equity (ROE) is -0.46 and return on invested capital (ROIC) is -92.02%.
- Return on Equity (ROE)
- -0.46
- Return on Assets (ROA)
- -0.68
- Return on Invested Capital (ROIC)
- -92.02%
- Return on Capital Employed (ROCE)
- -0.92
- Revenue Per Employee
- 0
- Profits Per Employee
- -5.64M
- Employee Count
- 13
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Sienna Biopharmaceuticals is -0.00. Sienna Biopharmaceuticals’s PEG ratio is -0.00.
- PE Ratio
- -0.00
- PS Ratio
- 0.00
- PB Ratio
- 0.00
- Price to FCF
- -0.00
- Price to Operating Cash Flow
- -0.00
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, Sienna Biopharmaceuticals had revenue of 0 and earned -73.31M in profits. Earnings per share was -3.59.
- Revenue
- 0
- Gross Profit
- -157.00K
- Operating Income
- -76.50M
- Pretax Income
- -73.47M
- Net Income
- -73.31M
- EBITDA
- -76.34M
- Earnings Per Share (EPS)
- -3.59
Cash Flow
In the last 12 months, operating cash flow was -54.63M and capital expenditures -10,000, giving a free cash flow of -54.64M billion.
- Operating Cash Flow
- -54.63M
- Free Cash Flow
- -54.64M
- Free Cash Flow per Share
- -3.02
Dividends & Yields
Sienna Biopharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -1997153.02%
- Earnings Yield
- -3585036.67%
Stock Price Statistics
- Beta
- -112.52
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 0.01
- 200-Day Moving Average
- 0.01
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Financial Position
Sienna Biopharmaceuticals as a current ratio of 2.07, with Debt / Equity ratio of 18.90%
- Current Ratio
- 2.07
- Quick Ratio
- 2.07
- Debt to Market Cap
- 0.63
- Net Debt to EBITDA
- 0.24
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Sienna Biopharmaceuticals has paid -157.00K in taxes.
- Income Tax
- -157.00K
- Effective Tax Rate
- 0.00
Enterprise Valuation
Sienna Biopharmaceuticals EV to EBITDA ratio is 0.24, with an EV/FCF ratio of 0.30.
- EV to Sales
- 0.00
- EV to EBITDA
- 0.24
- EV to Free Cash Flow
- 0.30
- EV to Operating Cash Flow
- 0.30
Balance Sheet
Sienna Biopharmaceuticals has $11.33M in cash and marketable securities with $0.00 in debt, giving a net cash position of $11.33M billion.
- Cash & Marketable Securities
- $11.33M
- Total Debt
- $0.00
- Net Cash
- $11.33M
- Net Cash Per Share
- $0.37
- Tangible Book Value Per Share
- -$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%

